Justin Burgess net worth and biography

Justin Burgess Biography and Net Worth

Justin Burgess is the Principal Accounting Officer & Controller at Dynavax Technologies.

What is Justin Burgess' net worth?

The estimated net worth of Justin Burgess is at least $45,515.74 as of May 17th, 2022. Mr. Burgess owns 3,854 shares of Dynavax Technologies stock worth more than $45,516 as of June 7th. This net worth estimate does not reflect any other investments that Mr. Burgess may own. Learn More about Justin Burgess' net worth.

How do I contact Justin Burgess?

The corporate mailing address for Mr. Burgess and other Dynavax Technologies executives is 2100 Powell Street Suite 900, Emeryville CA, 94608. Dynavax Technologies can also be reached via phone at (510) 848-5100 and via email at [email protected]. Learn More on Justin Burgess' contact information.

Has Justin Burgess been buying or selling shares of Dynavax Technologies?

Justin Burgess has not been actively trading shares of Dynavax Technologies during the last ninety days. Most recently, Justin Burgess sold 22,371 shares of the business's stock in a transaction on Monday, February 27th. The shares were sold at an average price of $10.38, for a transaction totalling $232,210.98. Learn More on Justin Burgess' trading history.

Who are Dynavax Technologies' active insiders?

Dynavax Technologies' insider roster includes Justin Burgess (Insider), Andrew Hack (Director), Robert Janssen (SVP), Kelly MacDonald (Sr. VP & CFO ), David Novack (COO), and Ryan Spencer (CEO). Learn More on Dynavax Technologies' active insiders.

Are insiders buying or selling shares of Dynavax Technologies?

In the last year, insiders at the biopharmaceutical company sold shares 8 times. They sold a total of 1,656,199 shares worth more than $19,562,582.64. The most recent insider tranaction occured on May, 4th when COO David F Novack sold 17,515 shares worth more than $190,913.50. Insiders at Dynavax Technologies own 9.3% of the company. Learn More about insider trades at Dynavax Technologies.

Information on this page was last updated on 5/4/2023.

Justin Burgess Insider Trading History at Dynavax Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/27/2023Sell22,371$10.38$232,210.98View SEC Filing Icon  
5/17/2022Sell6,000$10.00$60,000.003,854View SEC Filing Icon  
3/3/2022Sell21,490$10.58$227,364.20View SEC Filing Icon  
8/24/2021Sell5,768$15.00$86,520.009,489View SEC Filing Icon  
3/1/2021Sell2,958$8.88$26,267.041,221View SEC Filing Icon  
See Full Table

Justin Burgess Buying and Selling Activity at Dynavax Technologies

This chart shows Justin Burgess's buying and selling at Dynavax Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dynavax Technologies Company Overview

Dynavax Technologies logo
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Read More

Today's Range

Now: $11.77
Low: $11.43
High: $11.86

50 Day Range

MA: $10.85
Low: $9.65
High: $11.67

2 Week Range

Now: $11.77
Low: $9.42
High: $17.48


1,201,403 shs

Average Volume

1,336,793 shs

Market Capitalization

$1.50 billion

P/E Ratio


Dividend Yield